Drucker: A major area of focus has been on less invasive treatments. What are some innovations in minimally invasive devices, procedures and therapies, and what are the benefits in terms of patient care?
Dr. Almedhychy: The miniaturization of catheters and implants and heart devices has enabled easier procedures and faster recoveries. Additionally, the technological advances in the shaping of material and in the ability to design and iterate faster using computers and advanced algorithms has enabled us to treat larger entities in the heart, such as the valves, and do corrective surgeries from within the vessel. We also are benefitting from innovation on the pharmaceutical side, through the introduction of new drugs and drug classes.
Drucker: Can you share more about advancements in medicines?
Dr. Almedhychy: The treatment of cardiovascular disease involves not only correcting the structures of the cardiovascular system, but also treatment on the molecular side, and that's where pharmaceutical advances are important. Specifically, we are looking to improve patients' risk factors. We need anti-hypertensives, lipid-lowering drugs, and medications that protect the cardiovascular system from these very general diseases.